Search Results 21-30 of 801 for ���������������������������������������������:PC90���

  1. Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer - Mayo Clinic

    SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. Participation eligibility. Participant ...

  2. A Phase 1B Dose-escalation Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma - Mayo Clinic

    The purpose of the phase 2 portion is to estimate the PFS of patients with advanced soft tissue sarcoma by RECIST 1.1. Participation eligibility. Participant ...

  3. First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors - Mayo Clinic

    TP-0903 is a novel oral inhibitor that targets AXL kinase. Preclinical studies have shown promising antitumor activity of TP-0903 as a single agent against a ...

  4. A Randomized Phase 3 Trial of TRC105 and Pazopanib Versus Pazopanib Alone in Patients with Advanced Angiosarcoma (TAPPAS) - Mayo Clinic

    About this study. This is a study of TRC105 in combination with standard dose pazopanib compared to single agent pazopanib in patients with angiosarcoma not ...

  5. A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TRK-250 for Patients With Idiopathic Pulmonary Fibrosis - Mayo Clinic

    TRK-250 is a nucleic acid medicine that inhibits the progression of pulmonary fibrosis by selectively suppressing the expression of transforming growth factor- ...

  6. Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil - Mayo Clinic

    A secondary objective of this study is to evaluate the comparative bioavailability of treprostinil between two formulations of inhaled therapy. Participation ...

  7. Parkinson's Clinical Trials - Mayo Clinic Research

    The purpose of this study is to provide feasibility data for a novel method of defining patient-specific functional anatomic targets for Globus Pallidus ...

  8. First-in-Human Study of XMT-1536 in Cancers Likely to Express NaPi2b - Mayo Clinic

    About this study. The primary objective of this study is to determine the confirmed investigator-assessed objective response rate of XMT-1536 (upifitamab ...

  9. Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) - Mayo Clinic

    Clinical Trials · Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL) · More about research at ...

  10. A Study to Assess Imaging Studies of Neurodegenerative and Related Disorders - Mayo Clinic

    The purpose of this study is to perform longitudinal assessments in patients with neurodegenerative and related disorders to better understand the underlying ...